Dhingra Kapil 4
4 · Replimune Group, Inc. · Filed Dec 11, 2025
Insider Transaction Report
Form 4
Dhingra Kapil
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-09$1.75/sh+3,169$5,546→ 3,169 total - Sale
Common Stock
2025-12-09$10.40/sh−3,169$32,958→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-09−3,169→ 0 totalExercise: $1.75Exp: 2026-01-21→ Common Stock (3,169 underlying)
Footnotes (2)
- [F1]The reporting person exercised the option due to the upcoming expiration date of the option.
- [F2]All of the shares underlying this stock option vested on January 21, 2016.